News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website


FDA Grants Accurexa Pre-IND Meeting for its ACX-31 Program in the Treatment of Brain Cancer


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 This is a new platform for delivering treatments into the brain tumor directly. Higher dosages can be achieved in the tumor, with less or no exposure to the rest of the body. Work in mice showed that Temozolomide and BCNU given directly into the tumor work a lot better than the standard ways of giving it. Hopefully this will translate into patients quickly.



Website: http://finance.yahoo.com/news/fda-grants-accurexa-pre-ind-120000970.html

Posted on: 07/05/2016

FDA Grants Accurexa Pre-IND Meeting for its ACX-31 Program in the Treatment of Brain Cancer

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740